European Medicines Agency (EMA) with the European Commission; national competent authorities in each member state
Is Maridebart cafraglutide (MariTide) legal in European Union?
Not approvedInvestigational; no EU marketing authorisation and no application under evaluation
Not approved as a medicine here.
Maridebart cafraglutide does not appear in the Union Register or in EMA's September 2026 list of applications under evaluation. It has no EU authorisation. Under Article 6 of Directive 2001/83/EC, no medicine may be placed on the market without a marketing authorisation.
Last verified 2026-09-29 · how we verify
Maridebart cafraglutide (MariTide) elsewhere
Sources (3)
- 01Union Register of medicinal products for human useEuropean Commission · 2026-09-29 · accessed 2026-09-29
- 02Applications for new human medicines under evaluation by the CHMP (September 2026)European Medicines Agency · 2026-09-04 · accessed 2026-09-29
- 03Directive 2001/83/EC on the Community code relating to medicinal products for human use (consolidated text, 1 January 2025)European Union (EUR-Lex) · 2025-01-01 · accessed 2026-09-29